Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Micol Romano

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
International Journal of Clinical Practice|July 20, 2022
<i>Mycoplasma pneumoniae</i> Infections and Primary Immune DeficienciesDimitri Poddighe, Erkan Demirkaya, Vitaliy Sazonov, et al.
Seminars in Arthritis and Rheumatism|October 15, 2020
Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family membersAchille Marino, Micol Romano, Maurizio Gattinara, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 25, 2017
PachydermodactylyDimitri Poddighe, Micol Romano, Maurizio Gattinara, et al.
Current Medicinal Chemistry|May 24, 2018
Biologics for the Treatment of Juvenile Idiopathic ArthritisDimitri Poddighe, Micol Romano, Maurizio Gattinara, et al.
British Journal of Clinical Pharmacology|November 20, 2021
Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory diseaseDimitri Poddighe, Micol Romano, Facundo Garcia-Bournissen, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Familial Mediterranean Fever; Recent Advances, Future ProspectivesMicol Romano, David Piskin, Ovgu Kul Cinar, et al.
Journal of Clinical Medicine|March 11, 2020
New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and BeyondErkan Demirkaya, Sezgin Sahin, Micol Romano, et al.
Nature Reviews. Rheumatology|April 2, 2024
Time for a new approach to drug development for rare systemic autoinflammatory diseasesNatalie M Zitoun, Erkan Demirkaya, Raphaela Goldbach-Mansky, et al.
Journal of Clinical Immunology|April 6, 2026
Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 MutationMicol Romano, Erkan Demirkaya, Andréanne N Zizzo, et al.
Journal of Clinical Immunology|March 8, 2024
Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCDMicol Romano, Ashley Geerlink, Erkan Demirkaya, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
International Journal of Clinical Practice|July 20, 2022
<i>Mycoplasma pneumoniae</i> Infections and Primary Immune DeficienciesDimitri Poddighe, Erkan Demirkaya, Vitaliy Sazonov, et al.
Seminars in Arthritis and Rheumatism|October 15, 2020
Patients with juvenile idiopathic arthritis on TNF inhibitors exposed to COVID-19 family membersAchille Marino, Micol Romano, Maurizio Gattinara, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 25, 2017
PachydermodactylyDimitri Poddighe, Micol Romano, Maurizio Gattinara, et al.
Current Medicinal Chemistry|May 24, 2018
Biologics for the Treatment of Juvenile Idiopathic ArthritisDimitri Poddighe, Micol Romano, Maurizio Gattinara, et al.
British Journal of Clinical Pharmacology|November 20, 2021
Conventional and novel therapeutic options in children with familial Mediterranean fever: A rare autoinflammatory diseaseDimitri Poddighe, Micol Romano, Facundo Garcia-Bournissen, et al.
Diagnostics (Basel, Switzerland)|April 12, 2025
Familial Mediterranean Fever; Recent Advances, Future ProspectivesMicol Romano, David Piskin, Ovgu Kul Cinar, et al.
Journal of Clinical Medicine|March 11, 2020
New Horizons in the Genetic Etiology of Systemic Lupus Erythematosus and Lupus-Like Disease: Monogenic Lupus and BeyondErkan Demirkaya, Sezgin Sahin, Micol Romano, et al.
Nature Reviews. Rheumatology|April 2, 2024
Time for a new approach to drug development for rare systemic autoinflammatory diseasesNatalie M Zitoun, Erkan Demirkaya, Raphaela Goldbach-Mansky, et al.
Journal of Clinical Immunology|April 6, 2026
Anifrolumab to Treat Severe Hepatic Involvement in a De Novo IFIH1 MutationMicol Romano, Erkan Demirkaya, Andréanne N Zizzo, et al.
Journal of Clinical Immunology|March 8, 2024
Pharmacokinetics of Baricitinib in Cerebrospinal Fluid and Plasma in a Patient with SPENCDMicol Romano, Ashley Geerlink, Erkan Demirkaya, et al.
Pageof 5